|
 |
 |

Rotary feeder improves conveying efficiency
The ACS Valves Aero-Flow series of rotary feeders is designed to convey pharmaceutical ingredients efficiently. Air enters the feeder through its two endplates. As the air circulates around the endplates, the air pressure increases and prevents the ingredients from getting into the feeder's seals and bearings.
Air passes through a slot in the bottom of each endplate into the feeder housing and mixes with material being conveyed by the 10-vane rotor. The feeder thus aerates the material and helps it to flow freely. The aeration also helps to keep sticky or abrasive ingredients away from the feeder housing, endplates, and rotor, thus reducing wear on the unit.
In addition, the rotor design prevents material from building up inside the feeder. The precision tolerance of the 10-vane rotor design inside the unit prevents excess air from passing through the valve.
Advertisement:
Join SSCI, A Division of Aptuit, for an educational short course on Pharmaceutical Solids: Essential Knowledge and Advanced Concepts
On April 5 & 6, 2011, Dr. Stephen R. Byrn and Scientists from SSCI will present a 2-day overview of pharmaceutical solid-state research for process chemists, engineers, materials scientists, intellectual property attorneys and pharmaceutical scientists. Location: Hyatt at The Bellevue, Philadelphia, PA. Register today at: www.aptuit.com/ItsAllAbouttheServices/service.htm |
|
|
|
 |
Almac’s Clinical Technologies business unit has formed an exclusive integrated patient management alliance with Exco InTouch. The alliance will be focused on the integration of both technology and processes by both firms to deliver patient management, compliance, retention, and ePRO service offerings to sponsors of clinical trials.
Almac, a contract development and manufacturing organization, has announced an investment in two ZED automated inline wallet presses in Craigavon and Pennsylvania to reduce timelines associated with the use of blister card packaging.
Boehringer Ingelheim has entered into a pact to provide MorphoSys with process development and additional manufacturing for its early clinical-stage chronic lymphocytic leukemia candidate MOR208 and other drugs. MOR208 is an in-licensed antibody currently undergoing Phase I evaluation in the US by MorphoSys’ partner Xencor.
Advertisement:
Balances Deliver Speed, Durability, Precision
Quick…and to the point! Shimadzu balances deliver the performance, functionality, and value scientists need. The unique UniBloc one-piece manufacturing assembly assures stable temperature characteristics, excellent response, and a long operational life, while Windows® Direct Communication enables easy integration of weighing results with laboratory software.
Learn more... |
Novartis has completed the transaction to acquire an 85% stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical. This acquisition provides Novartis with an expanded presence in the Chinese vaccines market and is expected to facilitate the introduction of additional Novartis vaccines into China.
Merck and sanofi-aventis have mutually terminated their agreement to form a new animal health joint venture by combining Merial, the animal health business of sanofi-aventis, with Intervet/Schering-Plough, Merck's animal health unit. As a result, each party will keep its current, separate animal health assets and businesses.
Eli Lilly and Company announced today that patients should not use the alcohol prep pads made by the Triad Group that are contained in the black starter kits for Forteo®[teriparatide (rDNA origin) injection] in the United States. The Triad Group is recalling the alcohol prep pads due to potential contamination with the bacteria, Bacillus cereus, which could result in life threatening infections, especially in at-risk populations, including immune suppressed and surgical patients.
Advertisement:
Feel the empowerment that comes from knowing that SAFC is ready to meet your contract manufacturing needs with quality products, innovative ideas and superior service. We stand ready to work with you every step of the way, anticipating your needs and offering keen insight. If you missed us at Informex, please visit our website and discover for yourself the SAFC difference.
www.safcglobal.com |
Takeda's Millenium group has extended its ADC partnership with Seattle Genetics for the global development and commercialization of brentuximab vedotin (SGN-35).
Advertisement:
At Solvay Chemicals, we manufacture BICAR® Sodium Bicarbonate and Soda Ash IPH to meet the exacting specifications of the US and EP Pharmacopeias and National Formulary. Produced according to cGMP, these are the products of choice for API or excipient applications requiring effervescent or desiccant properties. Solvay Chemicals, Inc. is part of the Solvay Group, the leading global producer of sodium bicarbonate and soda ash.
http://www.solvaychemicals.us/marketsapplications/marketshidden/0,,40615-2-0,00.htm |
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to ptpress@advanstar.com |
|
|
Synergy has appointed Dr. Laura Barrow vice-president of clinical operations. She will be responsible for guiding Synergy's clinical programs, including the Phase II/III study for plecanatide, the company's lead drug candidate.
Valeant has named Michael Pearson, currently Valeant's chief executive officer, as chairman of the board of directors, replacing Robert A. Ingram, who remains on the Valeant board as an independent board director and lead director. Pearson will continue in his role as CEO and has agreed to extend his contract through to February 2017.
Lithera has announced the the appointment of George W. Mahaffey as president and chief executive officer. Mahaffey will also join the Lithera board of directors.
Advertisement:
Spirax Sarco Presents a Solution for the Prevention of Reverse Flow and Cross Contamination The CVS10 provides a solution to protect any item of equipment from pressure surges associated with hydraulic forces such as waterhammer.
Additional features include: full traceability of wetted materials
throughout the valve, .507psi (35mbar) opening pressure as standard, high kv value with minimal pressure loss, and a choice of surface finish to maintain sterility and reduce risk of microbial growth.
Read more |
|
|
|
 |
|
The US Pharmacopeia (USP) is seeking scientists from around the world for its 2011-2012 fellowship program. The two $50,000 research fellowship awards will be presented to the students whose proposed research best directly addresses specific USP scientific or research needs, according to a USP notice on the program. The deadline for submissions is May 20, 2011. Full details are online at www.usp.org/aboutUSP/careers/fellowship.html
In addition to the implementation training programs ICH has been conducting around the world during the past year, the organization is now posting on its website a consolidated training package. This package covers the integrated implementation of the ICH Q8, Q9, and Q10 guidelines including details on technical development, manufacturing , pharmaceutical quality systems, and regulatory expectations (e.g., dossier preparation, assessment, and GMP-inspections), according to an ICH press release.
Advertisement:
Thousands of pharmaceutical, biologic, generic, and contract services professionals gather annually at INTERPHEX (March 29-31, 2011, Javits Convention Center, New York City) to see new products, network, and learn about emerging trends surrounding drug manufacturing. At INTERPHEX 2011, you’ll find the solutions and education you need to ensure quality, improve efficiency, and solve your manufacturing and supply chain problems. Register for a free exhibit hall pass at
www.INTERPHEX.com |
|
 |
|
|
|
 |
|
|
| |
|
 |
INTERPHEX 2011
At INTERPHEX, I will be most interested in attending sessions about?
|

View the poll archive. |
|
|
|